Table 4.
Genes | Cellular Pathway | Near-Haploid B-ALL | Low-Hypodiploid B-ALL | ||||
---|---|---|---|---|---|---|---|
Mutation | Focal Deletion | Focal DEL + Mut | Mutation | Focal Deletion | Focal DEL + Mut | ||
NF1 | RTK/RAS pathway | 11/68 (16%) | 16/68 (24%) | 3/68 (4%) | 0 | 2/34 (6%) | 0 |
KRAS | 2/68 (3%) | 0 | 0 | 0 | 0 | 0 | |
NRAS | 10/68 (15%) | 0 | 0 | 0 | 0 | 0 | |
PTPN11 | 1/68 (1%) | 0 | 0 | 0 | 0 | 0 | |
FLT3 | 6/68 (9%) | 0 | 0 | 0 | 0 | 0 | |
CRLF2 | 0 | 2/68 (3%) * | 0 | 0 | 0 | 0 | |
MAPK1 | 1/68 (1%) | 0 | 0 | 0 | 0 | 0 | |
GAB2 | 0 | 2/68 (3%) | 0 | 0 | 1/34 (3%) | 0 | |
EPHA7 | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 | |
RASA2 | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 | |
IKZF1 | B-cell development | 0 | 3/68 (4%) | 0 | 0 | 1/34 (3%) | 0 |
IKZF2 | 1/68 (1%) | 0 | 0 | 0 | 18/34 (53%) | 0 | |
IKZF3 | 1/68 (1%) | 8/68 (12%) | 0 | 0 | 1/34 (3%) | 0 | |
PAX5 | 1/68 (1%) | 4/68 (6%) | 0 | 0 | 2/34 (6%) | 0 | |
EBF1 | 0 | 0 | 0 | 0 | 0 | 0 | |
VPREB1 | 0 | 3/68 (4%) | 0 | 0 | 2/34 (6%) | 0 | |
CDKN2A/B | Cell cycle and apoptosis | 0 | 15/68 (22%) | 0 | 0 | 8/34 (24%) | 0 |
TP53 | 2/68 (3%) | 0 | 0 | 31/34 (91%) | 0 | 0 | |
RB1 | 2/68 (3%) | 3/68 (4%) | 1/68 (1%) | 5/34 (15%) | 8/34 (24%) | 0 | |
ETV6 | Hematopoiesis | 1/68 (1%) | 3/68 (4%) | 1/68 (1%) | 0 | 0 | 0 |
Histone cluster (6p22) | Histone-related | 0 | 13/68 (19%) | 0 | 0 | 1/34 (3%) | 0 |
ARID1B | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 | |
PAG1 | BCR signalling | 1/68 (1%) | 6/68 (9%) | 0 | 0 | 1/34 (3%) | 0 |
ARPP21 | Calmodulin signalling | 0 | 1/68 (1%) | 0 | 0 | 0 | 0 |
SLX4IP (C20orf194) | Telomere length maintenance | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 |
CUL5 | Ubiquitin pathway | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 |
FAM53B | Wnt signalling | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 |
PDS5B (APRIN) | Cohesin complex | 0 | 2/68 (3%) | 0 | 0 | 0 | 0 |
ANKRD11 | Cell adhesion | 0 | 0 | 0 | 0 | 2/34 (6%) | 0 |
DMD | 0 | 0 | 0 | 0 | 1/34 (3%) | 0 |
* one patient encoding P2RY8-CRLF2.